Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 24:13:1209111.
doi: 10.3389/fonc.2023.1209111. eCollection 2023.

Intratumoral and peritumoral radiomics model based on abdominal ultrasound for predicting Ki-67 expression in patients with hepatocellular cancer

Affiliations

Intratumoral and peritumoral radiomics model based on abdominal ultrasound for predicting Ki-67 expression in patients with hepatocellular cancer

Hongwei Qian et al. Front Oncol. .

Abstract

Background: Hepatocellular cancer (HCC) is one of the most common tumors worldwide, and Ki-67 is highly important in the assessment of HCC. Our study aimed to evaluate the value of ultrasound radiomics based on intratumoral and peritumoral tissues in predicting Ki-67 expression levels in patients with HCC.

Methods: We conducted a retrospective analysis of ultrasonic and clinical data from 118 patients diagnosed with HCC through histopathological examination of surgical specimens in our hospital between September 2019 and January 2023. Radiomics features were extracted from ultrasound images of both intratumoral and peritumoral regions. To select the optimal features, we utilized the t-test and the least absolute shrinkage and selection operator (LASSO). We compared the area under the curve (AUC) values to determine the most effective modeling method. Subsequently, we developed four models: the intratumoral model, the peritumoral model, combined model #1, and combined model #2.

Results: Of the 118 patients, 64 were confirmed to have high Ki-67 expression while 54 were confirmed to have low Ki-67 expression. The AUC of the intratumoral model was 0.796 (0.649-0.942), and the AUC of the peritumoral model was 0.772 (0.619-0.926). Furthermore, combined model#1 yielded an AUC of 0.870 (0.751-0.989), and the AUC of combined model#2 was 0.762 (0.605-0.918). Among these models, combined model#1 showed the best performance in terms of AUC, accuracy, F1-score, and decision curve analysis (DCA).

Conclusion: We presented an ultrasound radiomics model that utilizes both intratumoral and peritumoral tissue information to accurately predict Ki-67 expression in HCC patients. We believe that incorporating both regions in a proper manner can enhance the diagnostic performance of the prediction model. Nevertheless, it is not sufficient to include both regions in the region of interest (ROI) without careful consideration.

Keywords: Ki-67 Antigen; computer assisted diagnosis; hepatocellular cancer; machine learning; radiomics; ultrasonography.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flowchart of the inclusions and exclusions criteria of participants.
Figure 2
Figure 2
Representative immunohistochemistry Ki-67 staining patterns and dot plots assessing the percentage of Ki-67 staining cells (original magnification, 200x). (A) Low Ki-67 expression (7%); (B) High Ki-67 expression (80%). Brown-stained nuclei were considered positive Ki-67 expression.
Figure 3
Figure 3
An example of delineating region of interest (ROI) on abdominal ultrasound imaging in ITK-SNAP software. (A): original image; (B): intratumoral ROI. (C): peritumoral ROI; (D): combined ROI (intratumoral tissue + peritumoral tissue).
Figure 4
Figure 4
Receiver operating characteristic (ROC) curve results from different modeling methods in the intratumoral model and peritumoral model. The SVM algorithm showed the highest diagnostic performance with an AUC value of 0.796 (0.649-0.942) in the intratumoral model (A) and 0.772 (0.619-0.926) in the peritumoral model (B).
Figure 5
Figure 5
The waterfall plot displays the model’s performance in the intratumoral model validation group (A) and the peritumoral model validation group (B). The height of each bar in the chart represented the model predicted value minus the cut-off. The bars above the y=0 line indicate that the model predicts high Ki-67 expression, while the bars below the y=0 line indicate that the model predicts low Ki-67 expression.
Figure 6
Figure 6
(A) Receiver operating characteristic curve analysis of combined model#1; (B) Receiver operating characteristic (ROC) curve results of different modeling methods in combined model#2. The LR algorithm showed the highest diagnostic performance with an AUC value of 0.762 (0.605-0.918).
Figure 7
Figure 7
The waterfall plot displays the model’s performance in combined model#1 validation group (A) and combined model#2 validation group (B). The height of each bar in the chart represented the model predicted value minus the cut-off. The bars above the y=0 line indicate that the model predicts high Ki-67 expression, while the bars below the y=0 line indicate that the model predicts low Ki-67 expression.
Figure 8
Figure 8
(A). Comparison of receiver operating characteristic curves for differentiation of the four models; (B). Calibration curve of combined model#1 presented a good agreement between the predicted and pathologically confirmed Ki-67 status with dotted line (actual calibration) closed to dashed line (perfect calibration); (C). Decision curves for the intratumoral model, peritumoral model, combined model#1, and combined model#2.

Similar articles

Cited by

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin (2021) 71(3):209–49. doi: 10.3322/caac.21660 - DOI - PubMed
    1. Fujiwara N, Friedman SL, Goossens N, Hoshida Y. Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine. J Hepatol. (2018) 68(3):526–49. doi: 10.1016/j.jhep.2017.09.016 - DOI - PMC - PubMed
    1. Wei W, Jian P-E, Li S-H, Guo Z-X, Zhang Y-F, Ling Y-H, et al. . Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety. Cancer Commun (Lond) (2018) 38(1):61. doi: 10.1186/s40880-018-0331-y - DOI - PMC - PubMed
    1. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol (1984) 133(4):1710–5. doi: 10.4049/jimmunol.133.4.1710 - DOI - PubMed
    1. Cao Y, Ke R, Wang S, Zhu X, Chen J, Huang C, et al. . DNA topoisomerase IIα and Ki67 are prognostic factors in patients with hepatocellular carcinoma. Oncol Lett (2017) 13(6):4109–16. doi: 10.3892/ol.2017.5999 - DOI - PMC - PubMed

LinkOut - more resources